United States Artificial Insemination Market Set to Grow at 7.8% CAGR, Reaching USD 3.8 Billion by 2030

 

As per MarkNtel Advisors Artificial Insemination (AI) is a fertility remedy approach that involves delivering sperm straight to the uterus or cervix in the hopes of becoming pregnant in both humans and animals. To improve the probability of pregnancy, these sperm are saved alive, cleaned, or frozen. Artificial insemination is done through a quick and painless method inclusive of donor semen (AID) or artificial insemination homologous (AIH).

 United States Artificial Insemination Market Systems Insights & Analysis:

The United States Artificial Insemination Market size was valued at around USD 2.4 billion in 2024 and is projected to reach USD 3.8 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 7.8% during the forecast period, i.e., 2025-30. Rising infertility rates, technological advancements, and changing social attitudes are some of the factors driving the significant growth of the United States Artificial Insemination Market. According to the Centers for Disease Control and Prevention (CDC), approximately 12% of women in the United States who are of reproductive age suffer from infertility, boosting the need for artificial insemination. Additionally, the growing incidences of identical-sex couples and single human beings trying to begin a family have made artificial insemination a common and vital fertility treatment. The growing recognition of non-traditional family fashions in individuals and couples in particular the ones within the LGBTQ+ community are using artificial insemination to become parents. Furthermore, sperm donation in artificial insemination is screened for infections and offers a safe alternative for those who might be worried about the risks of STDs.

In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2026 to 2032, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.

Explore the Insights – Download a Free Sample:  https://www.marknteladvisors.com/query/request-sample/us-artificial-insemination-market.html

United States Artificial Insemination Market Systems Market Segmentation:

  • By Type
    • Intrauterine - Market Size & Forecast 2020-2030, USD Million
    • Intracervical - Market Size & Forecast 2020-2030, USD Million
    • Intravaginal - Market Size & Forecast 2020-2030, USD Million
    • Intratubal - Market Size & Forecast 2020-2030, USD Million
  • By Source
    • AIH-Husband - Market Size & Forecast 2020-2030, USD Million
    • AID-Donor - Market Size & Forecast 2020-2030, USD Million
  • By End User
    • Fertility Centers - Market Size & Forecast 2020-2030, USD Million
    • Hospitals and Clinics - Market Size & Forecast 2020-2030, USD Million
    • Home- Based – Market Size & Forecast 2020-2030, USD Million
    • Others - Market Size & Forecast 2020-2030, USD Million
  • By Region
    • North
    • South
    • East
    • West

United States Artificial Insemination Market Recent Development:

  • October 2024: Hamilton Throne, Inc. announced a partnership with Alife Health for its AI Technology Embryo Assist which will be available on Hamilton Thorne Laser Systems. Using Alfie’s Clinical Decision Support (CDS) algorithm to identify the best embryo for transfer and smoothly create digital records of each embryo.
  • May 2024: Vitrolife agreed to buy all of eFertilitys stock. This purchase is an essential component of Vitrolife’s group's strategy to improve digitalization and standardization in IVF clinics around the world.

Report Delivery Format – Market research reports from MarkNtel Advisors are delivered in PDF, Excel, and PowerPoint formats. Once the payment is successfully processed, the report will be sent to your registered email within 24 hours.

United States Artificial Insemination Market Drivers:

Increasing Cases of Infertility Driving Market Growth – The growing number of human and animal infertility cases is one of the main factors propelling the artificial insemination (AI) market in the US. Higher infertility rates in humans are caused by several factors including delayed childbearing changes in lifestyle and medical conditions like obesity low sperm count and polycystic ovary syndrome (PCOS). Beginning in the mid to late 30s women’s egg production starts to decline in quality which increases market demand for AI.  In the United States, about 9% of men and 11% of women of childbearing age were infertile according to the NICHD. It affects up to 15% of heterosexual couples overall. This has surged the growing demand for assisted reproductive technologies (ART), inclusive of AI.

Read Full Report: - https://www.marknteladvisors.com/research-library/us-artificial-insemination-market.html

Report Highlights Essential Insights for Strategic Decision-Making

  • Detailed market size, share, and forecast analysis
    • In-depth pricing trends and segment-wise cost evaluations
    • Key industry strategiesincluding innovation, partnerships, and acquisitions
    • Critical value chain analysis and stakeholder profiling
    • Regional import-export market insights and trade flow assessment
    • Thorough competitive benchmarking of top hearing aid manufacturers
    • Identification of new growth opportunities and niche market segments
    • Overview of market trends, drivers, and challenges shaping future demand

Some of the leading players in the United States Artificial Insemination Market are:

  • Vitrolife
  • Medtronic
  • Hamilton Throne, Inc.
  • Bayer AG
  • Cook Medical
  • Hi-Tech Solutions
  • Genus
  • Pride Angel
  • JLG Enterprises, Inc.
  • Kitazato Corporation
  • Rocket Medical plc.
  • Others

Research Methodology Summary

A systematic approach is used to ensure accurate market insights, combining both bottom-up and top-down methodsData triangulation validates findings from multiple angles.

Key Steps:

  • Define objectives and research design
  • Collect data through surveys and interviews
  • Analyze and validate data using reliable tools
  • Forecast trends and deliver actionable insights

About us:

MarkNtel Advisors is a globally recognized market research and consulting firm delivering intelligence across the healthcare industry, spanning pharmaceuticals, medical devices, healthcare IT, and biotechnology. Our analysts combine domain expertise with innovation tracking to help healthcare organizations improve efficiency and patient outcomes. Through Consulting Services, we assist clients in interpreting insights, designing go-to-market strategies, and adapting to regulatory changes, fostering sustainable growth in the evolving global healthcare ecosystem.

Trending blog:

Reach Us:

MarkNtel Advisors

Sector 63, Noida, Uttar Pradesh-201301, India

Contact No: +91 8719999009

Email: sales@marknteladvisors.com

Comments

Popular posts from this blog

Southeast Asia Plant-Based Dairy Products Market 2030: Size, Growth Drivers & Competitive Landscape

Indonesia Mushroom Market 2030: Strategies of Forecast Insights

U.S. Catering Market Growth Outlook 2030: Trends, Volume & Opportunities